Takahashi M, Kaneto H, Ueno E, Watanabe J, Koida M, Ogawa H, Yajima H
Jpn J Pharmacol. 1979 Apr;29(2):203-9. doi: 10.1254/jjp.29.203.
We developed a radioimmunoassay of methionine-enkephalin (met-enk) which was found to be highly specific to the peptide and 1 pmol was the detection limit. Interference by the following peptides was practically negligible; leucine-enkephalin, LAP- or CNBr-treated met-end, alpha- and beta-endorphins. Morphine and its congeners were totally inert. Measurement of met-enk in rat brain P2 fraction revealed besides met-enk, the presence of the factor which cross-reacted with the antiserum and also appeared to bind with the brain opiate receptor. Though the nature of the factor has not yet been characterized, it is suggested that for qualitative assessment of the tissue level of met-enk, a method to selectively inactivate either the peptide or the factor should be developed first.
我们开发了一种甲硫氨酸脑啡肽(met-enk)的放射免疫测定法,该方法被发现对该肽具有高度特异性,检测限为1皮摩尔。以下肽类的干扰实际上可以忽略不计:亮氨酸脑啡肽、经LAP或溴化氰处理的met-end、α和β内啡肽。吗啡及其同系物完全无活性。对大鼠脑P2组分中met-enk的测量显示,除了met-enk外,还存在与抗血清发生交叉反应且似乎也与脑阿片受体结合的因子。尽管该因子的性质尚未确定,但建议为了对met-enk的组织水平进行定性评估,应首先开发一种选择性灭活该肽或该因子的方法。